参考文献:<?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /> 1.Mikawa K, Nishina K, TakapY, et al . Attenuation of cardiovascular responses totracheal extubation: comparison of verapamil, lidocaine, and verapamic-lidocaine combination. Anesth Analg, 1997,85:1005. 2.Hartley M, vaughan RS. Problems associated with tracheal extubation. Br J Anaesth,1993,71:561. 3.Stones JG, Goex P, Sear JW et al. Risk of myocardial ischaemia during anaesthesia in wtreated and untreated hypertensive patients. Br J Anaesth,1988,61:675. 4.林丽娜等,《国外医学》麻醉学与复苏分册,1997;18(2):15. 5.Lowrie A, Johnston PL, Fell D. et al. Cardiovascular and plasma catecholamine response to tracheal extubation . Br J Anaesth ,1992,68:261. 6.Wohlner EC, Usubag L, Jacoby RM, et al. Cardiovascular effects of extubation. Anesthesiology, 1979,51:s194. 7.Simtetos AL. Hulse J, Pritchett EL. pharacokinetics and pharmacodyna-mics of esmolol administered as intraven ous bolus. Clin Pharmacol Ther, 1987,41:1127. 8.Sum CY , Yacobi A , kartzinel R, et al. Kinetics of esmolol , an ultr-short-acting betablocker, and of its major metabolite.Clin Pharmacol Ther , 1983,34:427~434. 9.Wiest D. Esmolol. A review of its therapeutic efficacy and pharmacokietic characteristics. Clin Pharmacokint, 1995;28:190~202 10.The Esmolol Reserch Group. Intravenousesmolol for the treament of supraventricular tachyarrhythmia: results of a multicenter baseline-controlled safety and efficacy study in 160 patients. Am Heart J, 1986;12:498~505 |